asx announcements

ASX Announcements Archive 2009

22 Dec 2009

Commencement of Circadian non-executive director share plan

read more >>
07 Dec 2009

Circadian and CSIRO enter strategic research alliance

read more >>
19 Nov 2009

2009 AGM Managing Director's Presentation

read more >>
19 Nov 2009

2009 AGM Managing Director's Presentation

read more >>
19 Nov 2009

Results of Annual General Meeting

read more >>
10 Nov 2009

Merriman Presentation

read more >>
10 Nov 2009

CIR to present at Merriman Curhan Ford's US Investor Summit

read more >>
29 Oct 2009

Circadian subsidiary terminates licence to Ark Therapeutics

read more >>
16 Oct 2009

Open Briefing - CEO on Manufacturing Milestone and Update

read more >>
14 Oct 2009

Notice of Annual General Meeting

read more >>
14 Oct 2009

2009 Annual Report

read more >>
13 Oct 2009

Manuafacturing milestone achieved for cancer drug candidate VGX-300

read more >>
14 Sep 2009

Change of date for Circadian's 2009 AGM

read more >>
09 Sep 2009

Change of Director's Interest Notice - Robert Klupacs

read more >>
08 Sep 2009

Change in substantial holder

read more >>
07 Sep 2009

Circadian provides PerkinElmer with worldwide rights to market research products

read more >>
03 Sep 2009

Circadian Newsletter - September 2009

read more >>
25 Aug 2009

Initial Director's Interest Notice - Dr Errol Malta

read more >>
25 Aug 2009

Circadian granted key VEGF-C patent in Japan

read more >>
20 Aug 2009

Preliminary final report

read more >>
20 Aug 2009

Dr Errol Malta appointed non-executive director

read more >>
30 Jul 2009

Shares to be released from escrow

read more >>
09 Jul 2009

Corporate Presentation

read more >>
09 Jul 2009

Corporate Presentation

read more >>
30 Jun 2009

Appendix 3B - Employee incentive

read more >>
18 Jun 2009

Circadian granted key strategic VEGF-D patent in Europe for angiogenic applications

read more >>
03 Jun 2009

Circadian sponsors international conference on angiogenesis research

read more >>
22 May 2009

Circadian licensee Ark Therapeutics announces Trinam phase III study enrols first patient

read more >>
19 May 2009

Open Briefing - CEO on Recent Achievements

read more >>
13 May 2009

FINSIA Presentation

read more >>
13 May 2009

FINSIA presentation - "The Survivors: strong business and balance sheet"

read more >>
06 May 2009

Circadian Scientific Advisory Board Chairman, Prof. Kari Alitalo, wins prestigious award for biomedical research

read more >>
24 Apr 2009

BioMelbourne Network Presentation

read more >>
24 Apr 2009

Change of Director's Interest Notice - Dominique Fisher

read more >>
24 Apr 2009

BioMelbourne Network presentation - Transformation of Circadian

read more >>
22 Apr 2009

Circadian partner ImClone Systems demonstrates VEGFR-3 antibody improves anti-tumour effects of chemotherapy in mouse tumour models

read more >>
02 Apr 2009

Circadian Newsletter - April 2009

read more >>
26 Mar 2009

Corporate Presentation

read more >>
26 Mar 2009

Corporate Presentation

read more >>
02 Mar 2009

Open Briefing on Cancer Diagnostic Commercialisation

read more >>
25 Feb 2009

Circadian and Healthscope to commercialise Peter Mac Cancer Diagnostic

read more >>
09 Feb 2009

Half-Year Results & Operational Achievements

read more >>
22 Jan 2009

Open Briefing - CEO on Trinam Phase III Trial

read more >>
09 Jan 2009

Ark Therapeutics receives clearance to commence Phase 3 trial of Trinam

read more >>